EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction. [electronic resource]
Producer: 20180221Description: 85542-85550 p. digitalISSN:- 1949-2553
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Chi-Square Distribution
- Databases, Factual
- Disease Progression
- Disease-Free Survival
- Drug Interactions
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride -- pharmacology
- Female
- Gefitinib
- Humans
- Kaplan-Meier Estimate
- Karnofsky Performance Status
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Multivariate Analysis
- Mutation
- Proportional Hazards Models
- Protein Kinase Inhibitors -- adverse effects
- Proton Pump Inhibitors -- adverse effects
- Quinazolines -- pharmacology
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Singapore
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.